US20090308185A1 - Device for detecting analytes in fluid samples - Google Patents
Device for detecting analytes in fluid samples Download PDFInfo
- Publication number
- US20090308185A1 US20090308185A1 US12/091,368 US9136806A US2009308185A1 US 20090308185 A1 US20090308185 A1 US 20090308185A1 US 9136806 A US9136806 A US 9136806A US 2009308185 A1 US2009308185 A1 US 2009308185A1
- Authority
- US
- United States
- Prior art keywords
- chamber
- movable member
- lid
- liquid sample
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012530 fluid Substances 0.000 title claims description 22
- 238000012360 testing method Methods 0.000 claims abstract description 87
- 239000007788 liquid Substances 0.000 claims abstract description 50
- 239000012491 analyte Substances 0.000 claims abstract description 30
- 238000004891 communication Methods 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims description 15
- 238000003556 assay Methods 0.000 claims description 10
- 230000000881 depressing effect Effects 0.000 claims description 7
- 239000000463 material Substances 0.000 description 26
- 239000003153 chemical reaction reagent Substances 0.000 description 14
- 239000003814 drug Substances 0.000 description 12
- 238000007789 sealing Methods 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 210000002700 urine Anatomy 0.000 description 11
- 238000001514 detection method Methods 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 3
- 229960004242 dronabinol Drugs 0.000 description 3
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229940127240 opiate Drugs 0.000 description 3
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- -1 for example Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960004801 imipramine Drugs 0.000 description 2
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 229950002454 lysergide Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229960001252 methamphetamine Drugs 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 230000036963 noncompetitive effect Effects 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 208000001992 Autosomal Dominant Optic Atrophy Diseases 0.000 description 1
- 206010011906 Death Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001567553 Eryngium aquifolium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 241000913821 Macolor niger Species 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 238000013096 assay test Methods 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960005426 doxepin Drugs 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 238000012125 lateral flow test Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 229960002085 oxycodone Drugs 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229950010883 phencyclidine Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940072690 valium Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/007—Devices for taking samples of body liquids for taking urine samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0663—Whole sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0478—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure pistons
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Definitions
- the present invention relates to devices for the detection of analytes in fluid samples.
- diagnostic testing of body fluids is a common place activity.
- Employers, government agencies, sports teams and other organizations have also become increasingly involved in diagnostic testing to maintain safety in the workplace and to ensure compliance with laws, rules and regulations.
- testing devices for collecting body fluids, such as urine, and to detect the presence of a predetermined analyte (e.g. a drug and/or metabolite thereof, or an indicator of disease).
- a predetermined analyte e.g. a drug and/or metabolite thereof, or an indicator of disease.
- Such testing devices generally require that a sample be placed in a sample container and that a technician manually insert and submerge a portion of a testing strip into the sample, and then withdraw it to read the result.
- a sealed receptacle for preventing contact is desirable.
- Various means have been proposed for reducing the risk of contact as shown in U.S. Pat. No. 4,976,923, U.S. Pat. No. 5,429,804, and U.S. Pat. No. 6,726,879, which utilize testing devices having test strips mounted in their lids. In use, the container is inverted or tilted so that the sample can wet the strips to perform the test.
- the present invention provides a device for detecting the presence of an analyte in a liquid sample.
- the device has an opening for introducing the liquid sample into a first chamber for collecting the liquid sample, and a second chamber connected to the first chamber by a passageway and containing a test element.
- the device also has a third chamber connected to the second chamber by a channel and containing a movable member having first and second positions.
- the third chamber is divided by the movable member into first and second zones, and the first zone has a vent hole.
- the movable member is in contact with at least one wall of the third chamber to prevent gas communication between the first and second zones.
- the device can also have a lid for closing the opening.
- the test element can be an assay card containing one or more assay test strips.
- the movable member is a plunger.
- the plunger can contain a seal in contact with at least one wall of the third chamber to prevent gas communication between the first and second zones of the third chamber.
- the third chamber can also have a bottom, and in one embodiment the vent hole is situated on the bottom of the third chamber.
- the plunger has a push bar extending towards the opening of the container.
- the lid can have a surface that contacts and depresses the push bar when the lid is applied to the opening.
- the passageway has a diameter of less than 10 mm, or less than 9 mm, or less than 8 mm, or less than 7 mm, or less than 6 mm, or less than 5 mm, or less than 4 mm, or less than 3 mm.
- the present invention provides methods for detecting the presence of an analyte in a liquid sample.
- the methods involve introducing a liquid sample into a test device as described herein, causing the movable member to move from the first position to the second position and thereby causing a volume of air to be drawn from the second chamber into the third chamber, and thereby causing a volume of liquid to be drawn from the first chamber through the passageway and into the second chamber to contact the test element, and detecting the presence of the analyte in the sample.
- the methods involve contacting the lid with the push bar and depressing the push bar as the lid is applied to the device, and thereby causing the movable member to move from the first position to the second position.
- depressing the push bar and moving the movable member from the first position to the second position causes a negative air pressure gradient to form in the third chamber and the volume of air to be drawn from the second chamber into the third chamber.
- the movement of the volume of air from the second chamber to the third chamber can be the cause of a negative air pressure gradient forming in the second chamber.
- formation of a negative air pressure gradient is meant that a vacuum forms in one chamber, causing air to be “pulled” into the chamber from another chamber in order to fill the vacuum created.
- the air pressure gradient refers to a difference in internal air pressures between two chambers.
- the negative air pressure gradient in the second chamber causes the fluid sample to flow from the first chamber through the passageway to the second chamber, and thereby to contact the test element. Depressing the push bar and moving the movable member from the first position to the second position can cause a volume of air to escape from the first zone through the vent hole.
- FIG. 1 is an exploded perspective view of the device in accordance with the present invention.
- FIG. 2 is another exploded perspective view of the device in accordance with the present invention from a different aspect.
- FIG. 3 is a perspective view of the device in accordance with the present invention with a lid removed.
- FIG. 4 is a perspective view of the device in accordance with the present invention with a base removed.
- FIG. 5 is a cross-sectional view of the device in accordance with the present invention, wherein a liquid sample is received in both first and second chambers.
- FIG. 6 is an enlarged partial view of FIG. 5 , wherein the liquid sample is not shown in order to clearly illustrate the structure of a passageway.
- FIG. 7 is a cross-sectional view of the device in accordance with the present invention, showing a plunger is positioned at a first position and the liquid sample is received in only the first chamber.
- FIG. 8 is an enlarged partial view of FIG. 7 , wherein the liquid sample is not shown in order to clearly illustrate the structure of a channel.
- FIG. 9 is a cross-sectional view similar to FIG. 7 , wherein the plunger is positioned at a second position, and a portion of liquid sample has flown into the second chamber.
- the present invention provides devices and methods for determining the presence or amount of an analyte in a liquid sample.
- the device takes the form of a cup, which receives a liquid sample for analysis.
- the liquid sample is urine.
- the analyte can be any analyte, for example, glucose, a drug of abuse or a metabolite thereof.
- the device utilizes a system of chambers to move liquid sample through the device and detect the presence or amount of an analyte in the samples.
- the device has three chambers, and liquid sample can be moved from one chamber to another by force of air pressure.
- the surface tension of the liquid sample can be used to hold the liquid in one chamber until the user is prepared to move the sample to an adjacent chamber by application of air pressure to the chambers.
- the air pressure can take the form of an increase or a decrease (e.g., formation of a vacuum) in internal air pressure.
- the different chambers of the device are connected by passageways, channels, and vent holes, which allow for the transfer of air pressure and liquid between the chambers.
- the device also has a movable member situated in one of the chambers.
- the movable member is a plunger
- the chamber is a cylinder that houses the plunger.
- air is forced out of the third chamber and creates a vacuum that is transferred to the second chamber, which causes a break in surface tension of liquid situated in the first chamber, and thereby causes liquid to flow from the first to the second chamber.
- cylinder is meant a structure containing the movable member and within which the movable member is moved from a first position to a second position.
- the chamber is a cylinder, it need not have a perfectly cylindrical shape in all embodiments, but can vary in shape and size, or take one shape at one portion and another shape at another portion, as long as it still performs the functions required by the assay.
- the test element of the device is situated in the second chamber and analysis of the liquid sample therefore begins.
- the movable member has the form of a plunger-type structure having a generally cylindrical shape. But in other embodiments the movable member can take any suitable shape.
- the analyte may be an infectious agent or indicative of an infected state.
- the analyte may be a drug (for example a drug of abuse), a hormone, a protein, a nucleic acid molecule, an etiological agent, or a specific binding pair member.
- drug of abuse refers to a drug that is taken for non-medicinal reasons (usually for mind-altering effects). The abuse of such drugs can lead to physical and mental damage and (with some substances) dependence, addiction and/or death.
- DOAs examples include cocaine; amphetamines (e.g., black beauties, white bennies, dextroamphetamines, dexies, beans); methamphetamines (crank, meth, crystal, speed); barbiturates (Valium®, Roche Pharmaceuticals, Nutley, N.J.); sedatives (i.e.
- lysergic acid diethylamide LSD
- depressants downers, goofballs, barbs, blue devils, yellow jackets, ludes
- tricyclic antidepressants TCA, e.g., imipramine, amitriptyline and doxepin
- PCP phencyclidine
- THC tetrahydrocannabinol
- pot, dope, hash, weed, etc. e.g., morphine, opium, codeine, heroin, oxycodone.
- Legal drugs that are taken for medical reasons, but on which overdose can easily occur may also be tested for using these test strips, for example, tricyclic antidepressants (imipramine and the like) and over the counter products containing acetaminophen.
- test element can conveniently be selected as lateral flow test strips, which are widely available for testing a broad range of analytes.
- any suitable test element can be used in the present invention.
- test strips are available in a variety of formats, such as immunoassay or chemical test format, for detecting analytes of interest in a sample, such as a drug of abuse or a metabolite suggestive of health status. Test strips can also be configured for either noncompetitive or competitive assay formats. In some formats, the test strips have a bibulous material having a sample application zone, a reagent zone, and a test result zone. The sample is applied to the sample application zone and flows into the reagent zone by capillary action. In the reagent zone, the sample dissolves and mixes with reagents necessary for detection of the analyte (if present).
- the sample now carrying the reagents, continues to flow to the test results zone.
- Additional reagents are immobilized in the test results zone, such as a specific binding molecule for the analyte. These reagents react with and bind the analyte (if present) or one of the first reagents from the reagent zone.
- Labels for providing the detectable signal can be present in the reagent zone, or in a separate label zone.
- a signal is produced if the sample contains the analyte, and no signal is produced if the analyte is not present.
- a signal can be produced if no analyte is present, and no signal if analyte is present.
- test element When the test element is a test strip, it may be made of bibulous or non-bibulous material.
- a test strip can include more than one material, which are then in fluid communication.
- One material of a test strip may be overlaid on another material of the test strip, such as for example, filter paper overlaid on nitrocellulose.
- a test strip may include a region comprising one or more materials followed by a region comprising one or more different materials. In this case, the regions are in fluid communication and may or may not partially overlap one another.
- the material or materials of the test strip can be bound to a support or solid surface such as a supporting sheet of plastic, to increase its handling strength.
- one or more components of the signal producing system can be bound to the analyte detection zone of the test strip material in the same manner as specific binding members are bound to the test strip material, as described above.
- components of the signal producing system that are included in the sample application zone, the reagent zone, or the analyte detection zone of the test strip, or that are included throughout the test strip may be impregnated into one or more materials of the test strip. This can be achieved either by surface application of solutions of such components or by immersion of the one or more test strip materials into solutions of such components.
- test strip material is dried.
- components of the signal producing system that are included in the sample application zone, the reagent zone, or the analyte detection zone of the test strip, or that are included throughout the test strip, may be applied to the surface of one or more test strip materials of the test strip as was described for labeled reagents.
- the zones can be arranged as follows: sample application zone, one or more reagent zones, one or more test results determination zones, one or more control zones, one or more adulteration zones, and fluid absorbing zone. If the test results determination zone includes a control zone, preferably it follows the analyte detection zone of the test result determination zone. All of these zones, or combinations thereof, can be provided in a single strip of a single material. Alternatively, the zones are made of different materials and are linked together in fluid communication. For example, the different zones can be in direct or indirect fluid communication.
- the different zones can be jointed end-to-end to be in fluid communication, overlapped to be in fluid communication, or be communicated by another member, such a joining material, which is preferably bibulous such as filter paper, fiberglass or nitrocellulose.
- a joining material may communicate fluid from end-to-end joined zones or materials including such zones, end-to-end joined zones or materials including such zones that are not in fluid communication, or join zones or materials that include such zones that are overlapped (such as but not limited to from top to bottom) but not in fluid communication.
- the device of the invention can be used to collect a body fluid, such as urine, and to detect the presence or amount of an analyte contained therein (e.g. a drug of abuse and/or metabolite thereof).
- the device generally includes a container 111 having an opening 115 for collecting the liquid sample, a lid 101 for closing the opening, and at least one test element 137 for conducting a test.
- the lid 101 can be a lid that is screwed onto the device to be secured in place, but in other embodiments the lid can be snapped on or otherwise secured in place by any convenient means.
- the device can also contain a seal 109 for sealing the container shut when the lid 101 is applied.
- a movable member such as a plunger 149 that is movably received in the container 111 .
- the device includes a cup-like main body 111 and a base 151 that can be hermetically attached to a bottom of the main body 111 .
- the main body 111 has a number of vertical sidewalls 117 connected to each other, a round upper rim 113 connecting top ends of the sidewalls, and a generally flat bottom wall 207 connecting lower ends of the sidewalls.
- two inner walls 309 extend generally parallel to two adjacent sidewalls 117 and connect with them at top ends thereof, so as to define a second chamber 601 , which contains the test element.
- the upper rim 113 defines an opening 115 for introducing the liquid sample and can have threads that can mate with corresponding threads on the lid 101 during coupling of the lid to the container 313 .
- the device has a movable member, which can create an air pressure vacuum in certain chambers of the device when it is moved from a first to a second position.
- the movable member is a plunger 149 .
- a plunger housing 311 is formed in the interior of the main body 111 and in air communication with the second chamber 211 , which contains the test element.
- the plunger housing 311 forms the third chamber.
- the plunger housing 311 is shaped like an inverted funnel and includes a cylindrical lower section 303 opening at the bottom wall 207 of the main body 111 through a vent hole.
- the plunger housing also has a cylindrical upper section 307 which has a diameter smaller than that of the lower section 303 , and a tapered intermediate section 305 connecting the upper and lower sections.
- the lower section 303 of the plunger housing is partially connected to one of the inner walls 309 , and a channel 801 is defined in the connection area to allow air exchange between the third chamber 701 and the second chamber 601 .
- two chambers being in “air communication” or “gas communication” is meant that a change in the air pressure in one chamber will cause an air pressure change in the other chamber, or that it will cause fluid to be drawn into or expelled from one chamber to another, or that air is able to move between two (or more) chambers.
- the chambers of the device can be of any shape or form suitable to fulfill their function in the device.
- the third chamber can take a generally cylindrical, syringe-like, or funnel shape, but other shapes can also be used that can support the movable member and the first and second zones of the third chamber.
- the different zones of the third chamber can also take different forms.
- the second chamber can also take any shape that supports the test elements
- the first chamber can be of any shape that supports the introduction of liquid into the device.
- the bottom wall 207 of the main body (which forms the bottom of the first chamber) contains a passageway 205 therein connecting the first chamber to the second chamber 601 .
- the passageway 205 has a diameter that is too small to allow the fluid in the main body 111 to flow therethrough under air pressure that is substantially equal to atmospheric pressure. Fluid will flow from the first chamber into the second chamber under a vacuum of air pressure induced by movement of the movable member.
- the diameter of the passageway is less than 10 mm, or less than 9 mm, or less than 8 mm, or less than 7 mm, or less than 6 mm, or less than 5 mm, or less than 4 mm, or less than 3 mm, or even smaller.
- the diameter of the passageway 205 is about 4 mm, or about 5 mm, or about 3 mm, or 3-5 mm. While in the embodiment depicted the passageway is an opening between the first and second chamber, the passageway can also have other configurations.
- the passageway can be a sinuous groove defined in the bottom wall of the main body with a small sectional diameter, or any opening or passageway connecting the two chambers.
- the bottom wall 207 further includes an embossment 209 at a bottom surface thereof around the opened area.
- the base 151 can be permanently affixed to the main body 111 .
- the base 151 includes an upper wall 153 , a bottom wall 213 , and a fencing wall 155 connecting the upper wall 153 and bottom wall 213 .
- the fencing wall 155 and bottom wall 213 together define a cavity 157 which is a part of the second chamber 601 and receives a portion of the liquid sample.
- a groove 159 is defined in a top of the fencing wall 155 to engage with the embossment 209 on the bottom wall 207 of the main body 111 .
- the embossment 209 can be embedded in the groove 159 , and then an ultrasonic welding can be used to hermetically seal these two components.
- Various other methods can also be used to affix the base and the main body while ensuring a good seal therebetween. In various embodiments, thermal welding, gluing, or compressive ring gaskets all can be used.
- the base 151 further includes spaced retaining walls 161 for retaining the test element, a block wall 163 to block rapid rate fluid, and a vent hole 165 defined in the upper wall 153 . The performance and the function of the retaining walls, block wall, and vent hole will be described in detail below.
- the lid 101 can be coupled to the container 313 to seal the sample in the container. Additionally, in the present invention, the coupling of the lid 101 to the container can also can be used to initiate an assay, which will be described in further detail below.
- the lid 101 includes a top 103 and a downwardly-extending flange 105 which has a shape that corresponding to the shape of the rim 113 of the container 313 so that the flange can couple to the rim.
- the top 103 is formed with a circular depression 107 having a bottom surface 201 that can depress the movable member 215 while the lid 101 is being coupled to the container 313 .
- a sealing member 109 such as an O-ring can be positioned between the lid 101 and the container 313 to provide a seal therebetween.
- the test element can be in the form of a test card, which can be any type of device that is configured to assay a sample.
- the test element includes an assay card 119 for detecting the presence or amount of an analyte in the sample and the device further includes an adulteration test card 131 for detecting the contamination of the sample.
- Each card 119 ( 131 ) has a size and shape that is configured to be inserted into an upper portion 211 of the second chamber 601 of the device, and retained by the retaining walls 161 of the base 151 .
- the card can be retained by any suitable means within the second compartment 601 .
- each card 119 ( 131 ) can have a panel 121 ( 133 ) with a group of slots 123 ( 135 ) defined therein, a number of assay strips 125 or adulteration strips 137 retained in the slots, and a cover 127 ( 139 ) adhered to one surface of the panel having windows 129 ( 141 ) for observing the test result.
- the movable member 215 is movably present in a plunger housing 311 .
- the movable member is a plunger 215 .
- the plunger 215 includes an elongated push bar 147 extending through the upper portion 307 of the plunger housing 311 toward the opening 115 of the container 313 , a plunger body 149 connecting one end of the push bar 147 and having a size and shape that is configured to be movable in the lower portion 303 of the plunger housing 311 , and a first sealing ring 143 retained around the push bar 147 and a second sealing ring 145 retained around the plunger body 149 .
- the sealing rings 143 and 145 have the form of circular rubber or plastic rings. But the sealing rings can be made of any suitable material and can take any shape that functions within the device.
- the base 151 is permanently fixed to the main body 111 to form an integral container 313 .
- a first chamber 301 is defined in the interior of the main body 111 for storing the liquid sample introduced through the opening 115 .
- a second chamber 601 of the main body 111 can also include a cavity portion 157 defined in part by the base 151 , and an upper portion 211 for receiving the test element.
- a passageway 205 is provided to permit the liquid sample to flow from the first chamber 115 to the second chamber 601 .
- the passageway is sized so that the surface tension of the liquid sample will prevent the sample from flowing from the first to the second chamber until it is “pulled” or sucked into the second chamber by the vacuum created by depressing the plunger in the third chamber.
- the passageway 205 is a small size bore as hereinbefore mentioned.
- a third chamber 701 is defined in an interior of the plunger housing 311 , as shown in FIGS. 7 and 9 , when the plunger 311 is received in the plunger housing 311 , the first and second sealing rings, 143 and 145 respectively, serve to provide a seal within the third chamber 701 .
- the third chamber 701 contains a first zone 901 and a second zone 902 , where the first zone is the area below the movable member and the second zone is the area above the movable member. Therefore, the first and second zones change in volume as the movable member is moved from one position to a second position. When present, the sealing rings can divide the first zone from the second zone of the third chamber.
- the first zone 901 is the space in the third chamber below the second sealing ring 145
- the second zone 902 is the space defined above the first sealing ring 145 and below the second sealing ring 143 .
- the channel 801 allows the passage of air from the second chamber to the third chamber as the movable member is lowered in the third chamber.
- the channel 801 can take any suitable configuration, but is conveniently present as an opening allowing air communication between the second chamber and third chamber.
- a liquid sample such as urine
- Liquid sample placed into the first chamber 115 will remain in the first chamber and will not flow through the passageway 205 since the surface tension of the liquid sample is sufficient to prevent it from flowing through the passageway, until drawn through by a vacuum force created in the second chamber 601 .
- the lid 101 is then coupled to the container 313 , such as by screwing the lid onto the container.
- the plunger 215 is located at a first, raised position at the beginning of the assay.
- the top of the push bar 147 extends upward a sufficient distance in the first chamber so that when the lid is applied, the depression 107 in the lid will contact the top of the push bar.
- the plunger body 149 is located in the lower section 303 of the plunger housing 311 . In one embodiment the plunger body 149 abuts against a number of ribs projecting from an inner surface of the intermediate section 305 .
- the bottom surface 201 of the circular depression 107 comes into contact with the top of the push bar 147 , and exerts a downward force on the push bar to actuate movement of the plunger along its axial direction from the first, raised position to the second, lowered position.
- air is forced from the first zone out of the vent hole.
- a vacuum is created in the second zone, which causes air to be “pulled” in from the second chamber 601 into the second zone of the third chamber to fill the vacuum.
- the vent hole can be conveniently configured as an opening that allows the passage of air, but can also take any other suitable configuration consistent with its function.
- a barrier wall 163 is located directly in the flow path of fluid coming into the second chamber from the first chamber.
- This barrier wall 163 serves to block a portion of the liquid sample that enters the second chamber 601 and prevents the liquid sample from achieving a flow rate high enough to cause damage to the strips 125 , 137 or flooding thereof.
- the barrier wall 163 requires the fluid to turn at a right angle before contacting the test strips, therefore causing the liquid sample to slow down and contact one end of each strip 125 , 137 in a more orderly fashion. This facilitates the liquid sample advancing through the test strip by capillary action to the test line, and a visible result is shown in the result window 129 , 141 .
- the sidewalls 117 of the container 313 can be transparent or semi-transparent to enable visual observation of the strips therethrough.
- the liquid sample drawn into the second chamber 601 is of a volume that adequately submerges the test strips but does not cause flooding.
- the plunger 211 can be set during manufacture so that movement from the first position to the second position draws in an appropriate amount of liquid sample.
- the first position can also be preset in manufacture, but the second position can be controlled by the user.
- a mark can be provided as an indicator on the rim 113 to indicate that when the lid 101 screws to this line the plunger has reached the second position.
- the second position can be reached when the lid 101 is completely coupled to the container 313 .
- the user can begin the assay in a single step of securing the lid to the container, and the test can be performed.
- This example illustrates the general use of a device of the invention.
- Water was poured into five devices of the invention configured as urine cups. After one hour the water sample remained in the first chamber of the cup and had not entered the second chamber by passing through the passageway. The lids were then applied to the cups, thereby pressing down the push bar and moving the plunger from the first position to the second position as the lid was applied.
- This example illustrates the use of a device of the invention to detect drugs of abuse in human urine using a competitive assay.
- a line would appear at the test line when no analyte was present in the sample.
- a test strip was included to test for the following analytes: THC, opiates (OPI), PCP, and methamphetamine (MET).
- Samples of drug-free urine, urine at ⁇ 50% cutoff, urine at +50% cutoff, and 3 ⁇ cutoff were arranged. Each sample was analyzed in triplicate using a device of the invention by placing the urine sample in the cup and fastening the lid, thus beginning the assay.
Abstract
Description
- The present invention relates to devices for the detection of analytes in fluid samples.
- The following Background of the Invention is intended to aid the reader in understanding the invention and is not admitted to be prior art.
- In the health-care industry, diagnostic testing of body fluids is a common place activity. Employers, government agencies, sports teams and other organizations have also become increasingly involved in diagnostic testing to maintain safety in the workplace and to ensure compliance with laws, rules and regulations.
- It is generally necessary to utilize devices for collecting body fluids, such as urine, and to detect the presence of a predetermined analyte (e.g. a drug and/or metabolite thereof, or an indicator of disease). Such testing devices generally require that a sample be placed in a sample container and that a technician manually insert and submerge a portion of a testing strip into the sample, and then withdraw it to read the result. With the potential for contact with the sample by the technician and its associated health and contamination risks, a sealed receptacle for preventing contact is desirable. Various means have been proposed for reducing the risk of contact as shown in U.S. Pat. No. 4,976,923, U.S. Pat. No. 5,429,804, and U.S. Pat. No. 6,726,879, which utilize testing devices having test strips mounted in their lids. In use, the container is inverted or tilted so that the sample can wet the strips to perform the test.
- Recently, the use of testing devices by other than health care professionals has increased. Due to the fact that these tests are increasingly performed and evaluated by relatively unskilled technicians, the device should be simple to operate to ensure adequate submersion of the test strip and provide accurate results.
- Therefore, a continuing need exists for testing devices that require minimum manual operation while ensuring accurate and reliable test results.
- The present invention provides a device for detecting the presence of an analyte in a liquid sample. The device has an opening for introducing the liquid sample into a first chamber for collecting the liquid sample, and a second chamber connected to the first chamber by a passageway and containing a test element. The device also has a third chamber connected to the second chamber by a channel and containing a movable member having first and second positions. The third chamber is divided by the movable member into first and second zones, and the first zone has a vent hole. The movable member is in contact with at least one wall of the third chamber to prevent gas communication between the first and second zones.
- In one embodiment the device can also have a lid for closing the opening. The test element can be an assay card containing one or more assay test strips.
- In one embodiment of the device the movable member is a plunger. The plunger can contain a seal in contact with at least one wall of the third chamber to prevent gas communication between the first and second zones of the third chamber. The third chamber can also have a bottom, and in one embodiment the vent hole is situated on the bottom of the third chamber. In one embodiment the plunger has a push bar extending towards the opening of the container. The lid can have a surface that contacts and depresses the push bar when the lid is applied to the opening.
- In various embodiments of the device the passageway has a diameter of less than 10 mm, or less than 9 mm, or less than 8 mm, or less than 7 mm, or less than 6 mm, or less than 5 mm, or less than 4 mm, or less than 3 mm.
- In another aspect the present invention provides methods for detecting the presence of an analyte in a liquid sample. The methods involve introducing a liquid sample into a test device as described herein, causing the movable member to move from the first position to the second position and thereby causing a volume of air to be drawn from the second chamber into the third chamber, and thereby causing a volume of liquid to be drawn from the first chamber through the passageway and into the second chamber to contact the test element, and detecting the presence of the analyte in the sample.
- In one embodiment the methods involve contacting the lid with the push bar and depressing the push bar as the lid is applied to the device, and thereby causing the movable member to move from the first position to the second position. In one embodiment depressing the push bar and moving the movable member from the first position to the second position causes a negative air pressure gradient to form in the third chamber and the volume of air to be drawn from the second chamber into the third chamber. The movement of the volume of air from the second chamber to the third chamber can be the cause of a negative air pressure gradient forming in the second chamber. By formation of a negative air pressure gradient is meant that a vacuum forms in one chamber, causing air to be “pulled” into the chamber from another chamber in order to fill the vacuum created. The air pressure gradient refers to a difference in internal air pressures between two chambers.
- In one embodiment the negative air pressure gradient in the second chamber causes the fluid sample to flow from the first chamber through the passageway to the second chamber, and thereby to contact the test element. Depressing the push bar and moving the movable member from the first position to the second position can cause a volume of air to escape from the first zone through the vent hole.
- The summary of the invention described above is not limiting and other features and advantages of the invention will be apparent from the following detailed description, as well as from the claims.
-
FIG. 1 is an exploded perspective view of the device in accordance with the present invention. -
FIG. 2 is another exploded perspective view of the device in accordance with the present invention from a different aspect. -
FIG. 3 is a perspective view of the device in accordance with the present invention with a lid removed. -
FIG. 4 is a perspective view of the device in accordance with the present invention with a base removed. -
FIG. 5 is a cross-sectional view of the device in accordance with the present invention, wherein a liquid sample is received in both first and second chambers. -
FIG. 6 is an enlarged partial view ofFIG. 5 , wherein the liquid sample is not shown in order to clearly illustrate the structure of a passageway. -
FIG. 7 is a cross-sectional view of the device in accordance with the present invention, showing a plunger is positioned at a first position and the liquid sample is received in only the first chamber. -
FIG. 8 is an enlarged partial view ofFIG. 7 , wherein the liquid sample is not shown in order to clearly illustrate the structure of a channel. -
FIG. 9 is a cross-sectional view similar toFIG. 7 , wherein the plunger is positioned at a second position, and a portion of liquid sample has flown into the second chamber. - The present invention provides devices and methods for determining the presence or amount of an analyte in a liquid sample. In one embodiment the device takes the form of a cup, which receives a liquid sample for analysis. In one embodiment the liquid sample is urine. The analyte can be any analyte, for example, glucose, a drug of abuse or a metabolite thereof.
- The device utilizes a system of chambers to move liquid sample through the device and detect the presence or amount of an analyte in the samples. In one embodiment the device has three chambers, and liquid sample can be moved from one chamber to another by force of air pressure. The surface tension of the liquid sample can be used to hold the liquid in one chamber until the user is prepared to move the sample to an adjacent chamber by application of air pressure to the chambers. In various embodiments the air pressure can take the form of an increase or a decrease (e.g., formation of a vacuum) in internal air pressure. The different chambers of the device are connected by passageways, channels, and vent holes, which allow for the transfer of air pressure and liquid between the chambers. The device also has a movable member situated in one of the chambers. In one embodiment the movable member is a plunger, and the chamber is a cylinder that houses the plunger. When the plunger is moved from a first position to a second position, air is forced out of the third chamber and creates a vacuum that is transferred to the second chamber, which causes a break in surface tension of liquid situated in the first chamber, and thereby causes liquid to flow from the first to the second chamber. By cylinder is meant a structure containing the movable member and within which the movable member is moved from a first position to a second position. When the chamber is a cylinder, it need not have a perfectly cylindrical shape in all embodiments, but can vary in shape and size, or take one shape at one portion and another shape at another portion, as long as it still performs the functions required by the assay.
- In one embodiment the test element of the device is situated in the second chamber and analysis of the liquid sample therefore begins. In the embodiment depicted in the Figures, the movable member has the form of a plunger-type structure having a generally cylindrical shape. But in other embodiments the movable member can take any suitable shape.
- A variety of analytes can be detected or quantified by the test elements in the present invention. The analyte may be an infectious agent or indicative of an infected state. The analyte may be a drug (for example a drug of abuse), a hormone, a protein, a nucleic acid molecule, an etiological agent, or a specific binding pair member. The term “drug of abuse” (DOA) refers to a drug that is taken for non-medicinal reasons (usually for mind-altering effects). The abuse of such drugs can lead to physical and mental damage and (with some substances) dependence, addiction and/or death. Examples of DOAs include cocaine; amphetamines (e.g., black beauties, white bennies, dextroamphetamines, dexies, beans); methamphetamines (crank, meth, crystal, speed); barbiturates (Valium®, Roche Pharmaceuticals, Nutley, N.J.); sedatives (i.e. sleep-aids); lysergic acid diethylamide (LSD); depressants (downers, goofballs, barbs, blue devils, yellow jackets, ludes); tricyclic antidepressants (TCA, e.g., imipramine, amitriptyline and doxepin); phencyclidine (PCP); tetrahydrocannabinol (THC, pot, dope, hash, weed, etc.); and opiates (e.g., morphine, opium, codeine, heroin, oxycodone). Legal drugs that are taken for medical reasons, but on which overdose can easily occur may also be tested for using these test strips, for example, tricyclic antidepressants (imipramine and the like) and over the counter products containing acetaminophen.
- The test element can conveniently be selected as lateral flow test strips, which are widely available for testing a broad range of analytes. However, any suitable test element can be used in the present invention.
- A variety of test elements can be incorporated into the present invention. One type of test element is a test strip. Test strips are available in a variety of formats, such as immunoassay or chemical test format, for detecting analytes of interest in a sample, such as a drug of abuse or a metabolite suggestive of health status. Test strips can also be configured for either noncompetitive or competitive assay formats. In some formats, the test strips have a bibulous material having a sample application zone, a reagent zone, and a test result zone. The sample is applied to the sample application zone and flows into the reagent zone by capillary action. In the reagent zone, the sample dissolves and mixes with reagents necessary for detection of the analyte (if present). The sample, now carrying the reagents, continues to flow to the test results zone. Additional reagents are immobilized in the test results zone, such as a specific binding molecule for the analyte. These reagents react with and bind the analyte (if present) or one of the first reagents from the reagent zone. Labels for providing the detectable signal can be present in the reagent zone, or in a separate label zone.
- Typically, in noncompetitive formats, a signal is produced if the sample contains the analyte, and no signal is produced if the analyte is not present. In competitive formats, a signal can be produced if no analyte is present, and no signal if analyte is present.
- When the test element is a test strip, it may be made of bibulous or non-bibulous material. A test strip can include more than one material, which are then in fluid communication. One material of a test strip may be overlaid on another material of the test strip, such as for example, filter paper overlaid on nitrocellulose. Alternatively or in addition, a test strip may include a region comprising one or more materials followed by a region comprising one or more different materials. In this case, the regions are in fluid communication and may or may not partially overlap one another. The material or materials of the test strip can be bound to a support or solid surface such as a supporting sheet of plastic, to increase its handling strength.
- In embodiments where the analyte is detected by a signal producing system, such as by one or more enzymes that specifically react with the analyte, one or more components of the signal producing system can be bound to the analyte detection zone of the test strip material in the same manner as specific binding members are bound to the test strip material, as described above. Alternatively or in addition, components of the signal producing system that are included in the sample application zone, the reagent zone, or the analyte detection zone of the test strip, or that are included throughout the test strip, may be impregnated into one or more materials of the test strip. This can be achieved either by surface application of solutions of such components or by immersion of the one or more test strip materials into solutions of such components. Following one or more applications or one or more immersions, the test strip material is dried. Alternatively or in addition, components of the signal producing system that are included in the sample application zone, the reagent zone, or the analyte detection zone of the test strip, or that are included throughout the test strip, may be applied to the surface of one or more test strip materials of the test strip as was described for labeled reagents.
- The zones can be arranged as follows: sample application zone, one or more reagent zones, one or more test results determination zones, one or more control zones, one or more adulteration zones, and fluid absorbing zone. If the test results determination zone includes a control zone, preferably it follows the analyte detection zone of the test result determination zone. All of these zones, or combinations thereof, can be provided in a single strip of a single material. Alternatively, the zones are made of different materials and are linked together in fluid communication. For example, the different zones can be in direct or indirect fluid communication. In this instance, the different zones can be jointed end-to-end to be in fluid communication, overlapped to be in fluid communication, or be communicated by another member, such a joining material, which is preferably bibulous such as filter paper, fiberglass or nitrocellulose. In using a joining material, a joining material may communicate fluid from end-to-end joined zones or materials including such zones, end-to-end joined zones or materials including such zones that are not in fluid communication, or join zones or materials that include such zones that are overlapped (such as but not limited to from top to bottom) but not in fluid communication.
- Referring to
FIGS. 1 and 2 , the device of the invention can be used to collect a body fluid, such as urine, and to detect the presence or amount of an analyte contained therein (e.g. a drug of abuse and/or metabolite thereof). The device generally includes acontainer 111 having anopening 115 for collecting the liquid sample, alid 101 for closing the opening, and at least onetest element 137 for conducting a test. In one embodiment thelid 101 can be a lid that is screwed onto the device to be secured in place, but in other embodiments the lid can be snapped on or otherwise secured in place by any convenient means. The device can also contain aseal 109 for sealing the container shut when thelid 101 is applied. Inside of thefirst container 111 is provided a movable member, such as aplunger 149 that is movably received in thecontainer 111. - The parts of the device can be formed or molded from any suitable material. For example, a variety of plastics can be used. Referring to the embodiment illustrated in the Figures, the device includes a cup-like
main body 111 and a base 151 that can be hermetically attached to a bottom of themain body 111. With reference toFIGS. 3 , 5, 7, and 9, themain body 111 has a number ofvertical sidewalls 117 connected to each other, a roundupper rim 113 connecting top ends of the sidewalls, and a generally flatbottom wall 207 connecting lower ends of the sidewalls. In this embodiment twoinner walls 309 extend generally parallel to twoadjacent sidewalls 117 and connect with them at top ends thereof, so as to define asecond chamber 601, which contains the test element. Theupper rim 113 defines anopening 115 for introducing the liquid sample and can have threads that can mate with corresponding threads on thelid 101 during coupling of the lid to thecontainer 313. - The device has a movable member, which can create an air pressure vacuum in certain chambers of the device when it is moved from a first to a second position. In the embodiment illustrated in the Figures, the movable member is a
plunger 149. Aplunger housing 311 is formed in the interior of themain body 111 and in air communication with thesecond chamber 211, which contains the test element. Theplunger housing 311 forms the third chamber. In this embodiment theplunger housing 311 is shaped like an inverted funnel and includes a cylindricallower section 303 opening at thebottom wall 207 of themain body 111 through a vent hole. The plunger housing also has a cylindricalupper section 307 which has a diameter smaller than that of thelower section 303, and a taperedintermediate section 305 connecting the upper and lower sections. As shown inFIG. 7 and detailed inFIG. 8 , in this embodiment thelower section 303 of the plunger housing is partially connected to one of theinner walls 309, and achannel 801 is defined in the connection area to allow air exchange between thethird chamber 701 and thesecond chamber 601. By two chambers being in “air communication” or “gas communication” is meant that a change in the air pressure in one chamber will cause an air pressure change in the other chamber, or that it will cause fluid to be drawn into or expelled from one chamber to another, or that air is able to move between two (or more) chambers. - The chambers of the device can be of any shape or form suitable to fulfill their function in the device. In one embodiment the third chamber can take a generally cylindrical, syringe-like, or funnel shape, but other shapes can also be used that can support the movable member and the first and second zones of the third chamber. Also, the different zones of the third chamber can also take different forms. Similarly, the second chamber can also take any shape that supports the test elements, and the first chamber can be of any shape that supports the introduction of liquid into the device.
- The
bottom wall 207 of the main body (which forms the bottom of the first chamber) contains apassageway 205 therein connecting the first chamber to thesecond chamber 601. Thepassageway 205 has a diameter that is too small to allow the fluid in themain body 111 to flow therethrough under air pressure that is substantially equal to atmospheric pressure. Fluid will flow from the first chamber into the second chamber under a vacuum of air pressure induced by movement of the movable member. In various embodiments the diameter of the passageway is less than 10 mm, or less than 9 mm, or less than 8 mm, or less than 7 mm, or less than 6 mm, or less than 5 mm, or less than 4 mm, or less than 3 mm, or even smaller. In one embodiment, the diameter of thepassageway 205 is about 4 mm, or about 5 mm, or about 3 mm, or 3-5 mm. While in the embodiment depicted the passageway is an opening between the first and second chamber, the passageway can also have other configurations. For example, in various embodiments the passageway can be a sinuous groove defined in the bottom wall of the main body with a small sectional diameter, or any opening or passageway connecting the two chambers. Thebottom wall 207 further includes anembossment 209 at a bottom surface thereof around the opened area. - The base 151 can be permanently affixed to the
main body 111. Thebase 151 includes anupper wall 153, abottom wall 213, and afencing wall 155 connecting theupper wall 153 andbottom wall 213. Thefencing wall 155 andbottom wall 213 together define acavity 157 which is a part of thesecond chamber 601 and receives a portion of the liquid sample. In this embodiment agroove 159 is defined in a top of thefencing wall 155 to engage with theembossment 209 on thebottom wall 207 of themain body 111. In assembling themain body 111 and thebase 151, theembossment 209 can be embedded in thegroove 159, and then an ultrasonic welding can be used to hermetically seal these two components. Various other methods can also be used to affix the base and the main body while ensuring a good seal therebetween. In various embodiments, thermal welding, gluing, or compressive ring gaskets all can be used. The base 151 further includes spaced retainingwalls 161 for retaining the test element, ablock wall 163 to block rapid rate fluid, and avent hole 165 defined in theupper wall 153. The performance and the function of the retaining walls, block wall, and vent hole will be described in detail below. - The
lid 101 can be coupled to thecontainer 313 to seal the sample in the container. Additionally, in the present invention, the coupling of thelid 101 to the container can also can be used to initiate an assay, which will be described in further detail below. In this embodiment thelid 101 includes a top 103 and a downwardly-extendingflange 105 which has a shape that corresponding to the shape of therim 113 of thecontainer 313 so that the flange can couple to the rim. In the embodiment depicted, the top 103 is formed with acircular depression 107 having abottom surface 201 that can depress themovable member 215 while thelid 101 is being coupled to thecontainer 313. A sealingmember 109, such as an O-ring can be positioned between thelid 101 and thecontainer 313 to provide a seal therebetween. - The test element can be in the form of a test card, which can be any type of device that is configured to assay a sample. In this embodiment, the test element includes an
assay card 119 for detecting the presence or amount of an analyte in the sample and the device further includes anadulteration test card 131 for detecting the contamination of the sample. Each card 119 (131) has a size and shape that is configured to be inserted into anupper portion 211 of thesecond chamber 601 of the device, and retained by the retainingwalls 161 of thebase 151. In other embodiments the card can be retained by any suitable means within thesecond compartment 601. In various embodiments each card 119 (131) can have a panel 121 (133) with a group of slots 123 (135) defined therein, a number of assay strips 125 oradulteration strips 137 retained in the slots, and a cover 127 (139) adhered to one surface of the panel having windows 129 (141) for observing the test result. - The
movable member 215 is movably present in aplunger housing 311. In this embodiment, the movable member is aplunger 215. Theplunger 215 includes anelongated push bar 147 extending through theupper portion 307 of theplunger housing 311 toward theopening 115 of thecontainer 313, aplunger body 149 connecting one end of thepush bar 147 and having a size and shape that is configured to be movable in thelower portion 303 of theplunger housing 311, and afirst sealing ring 143 retained around thepush bar 147 and asecond sealing ring 145 retained around theplunger body 149. In the embodiment depicted in the Figures the sealing rings 143 and 145 have the form of circular rubber or plastic rings. But the sealing rings can be made of any suitable material and can take any shape that functions within the device. - With reference to
FIGS. 5-9 , in this embodiment thebase 151 is permanently fixed to themain body 111 to form anintegral container 313. In this assembled state, afirst chamber 301 is defined in the interior of themain body 111 for storing the liquid sample introduced through theopening 115. Asecond chamber 601 of themain body 111 can also include acavity portion 157 defined in part by thebase 151, and anupper portion 211 for receiving the test element. Apassageway 205 is provided to permit the liquid sample to flow from thefirst chamber 115 to thesecond chamber 601. The passageway is sized so that the surface tension of the liquid sample will prevent the sample from flowing from the first to the second chamber until it is “pulled” or sucked into the second chamber by the vacuum created by depressing the plunger in the third chamber. In the present embodiment, thepassageway 205 is a small size bore as hereinbefore mentioned. - A
third chamber 701 is defined in an interior of theplunger housing 311, as shown inFIGS. 7 and 9 , when theplunger 311 is received in theplunger housing 311, the first and second sealing rings, 143 and 145 respectively, serve to provide a seal within thethird chamber 701. Thethird chamber 701 contains afirst zone 901 and asecond zone 902, where the first zone is the area below the movable member and the second zone is the area above the movable member. Therefore, the first and second zones change in volume as the movable member is moved from one position to a second position. When present, the sealing rings can divide the first zone from the second zone of the third chamber. In the embodiment depicted, thefirst zone 901 is the space in the third chamber below thesecond sealing ring 145, and thesecond zone 902 is the space defined above thefirst sealing ring 145 and below thesecond sealing ring 143. As theplunger 215 moves in thethird chamber 701, the first and second sealing rings, 143, 145 respectively, remain in contact with the inner surface of the upper andlower portions plunger housing 311 to prevent air communication between the first andsecond zones channel 801 allows the passage of air from the second chamber to the third chamber as the movable member is lowered in the third chamber. Thechannel 801 can take any suitable configuration, but is conveniently present as an opening allowing air communication between the second chamber and third chamber. - In use, a liquid sample, such as urine, is first introduced into the first chamber of the container. Liquid sample placed into the
first chamber 115 will remain in the first chamber and will not flow through thepassageway 205 since the surface tension of the liquid sample is sufficient to prevent it from flowing through the passageway, until drawn through by a vacuum force created in thesecond chamber 601. - The
lid 101 is then coupled to thecontainer 313, such as by screwing the lid onto the container. With reference toFIG. 7 , theplunger 215 is located at a first, raised position at the beginning of the assay. In the first position, the top of thepush bar 147 extends upward a sufficient distance in the first chamber so that when the lid is applied, thedepression 107 in the lid will contact the top of the push bar. Theplunger body 149 is located in thelower section 303 of theplunger housing 311. In one embodiment theplunger body 149 abuts against a number of ribs projecting from an inner surface of theintermediate section 305. When the plunger is in the first, raised position, the volume of air in thesecond zone 902 of thethird chamber 701 is relatively small relative to the volume of air in thesecond zone 902 when theplunger body 149 is in the second, lowered position. - When the
lid 101 is screwed onto the container, thebottom surface 201 of thecircular depression 107 comes into contact with the top of thepush bar 147, and exerts a downward force on the push bar to actuate movement of the plunger along its axial direction from the first, raised position to the second, lowered position. With the movement of the plunger from the first position to the second position, air is forced from the first zone out of the vent hole. At the same time, a vacuum is created in the second zone, which causes air to be “pulled” in from thesecond chamber 601 into the second zone of the third chamber to fill the vacuum. This action thereby also creates a corresponding vacuum in thesecond chamber 601, which “pulls” fluid sample in thefirst chamber 115 through thepassageway 205 and into thesecond chamber 601 to neutralize the vacuum, since the force of the vacuum is sufficient to overcome the surface tension of the liquid sample over the passageway. This therefore causes the fluid sample to contact the test elements in theupper portion 211 of the second chamber. The vent hole can be conveniently configured as an opening that allows the passage of air, but can also take any other suitable configuration consistent with its function. - Referring to
FIGS. 5 and 6 , in one embodiment abarrier wall 163 is located directly in the flow path of fluid coming into the second chamber from the first chamber. Thisbarrier wall 163 serves to block a portion of the liquid sample that enters thesecond chamber 601 and prevents the liquid sample from achieving a flow rate high enough to cause damage to thestrips barrier wall 163 requires the fluid to turn at a right angle before contacting the test strips, therefore causing the liquid sample to slow down and contact one end of eachstrip result window sidewalls 117 of thecontainer 313 can be transparent or semi-transparent to enable visual observation of the strips therethrough. - As shown in
FIG. 9 , when theplunger 211 is moved from the first position to the second position, the liquid sample drawn into thesecond chamber 601 is of a volume that adequately submerges the test strips but does not cause flooding. Theplunger 211 can be set during manufacture so that movement from the first position to the second position draws in an appropriate amount of liquid sample. Additionally, the first position can also be preset in manufacture, but the second position can be controlled by the user. For example, a mark can be provided as an indicator on therim 113 to indicate that when thelid 101 screws to this line the plunger has reached the second position. In this embodiment, the second position can be reached when thelid 101 is completely coupled to thecontainer 313. Thus, the user can begin the assay in a single step of securing the lid to the container, and the test can be performed. - This example illustrates the general use of a device of the invention. Water was poured into five devices of the invention configured as urine cups. After one hour the water sample remained in the first chamber of the cup and had not entered the second chamber by passing through the passageway. The lids were then applied to the cups, thereby pressing down the push bar and moving the plunger from the first position to the second position as the lid was applied.
- After 5 minutes, it was observed that water had entered the second chamber through the passageway. The water sample wetted the test strips without flooding them. The cup was then placed into a barometric container and subjected to a barometric pressure of 0.7 for 3 minutes. No leaking was observed to occur.
- This example illustrates the use of a device of the invention to detect drugs of abuse in human urine using a competitive assay. Thus, a line would appear at the test line when no analyte was present in the sample. A test strip was included to test for the following analytes: THC, opiates (OPI), PCP, and methamphetamine (MET).
- Samples of drug-free urine, urine at −50% cutoff, urine at +50% cutoff, and 3× cutoff were arranged. Each sample was analyzed in triplicate using a device of the invention by placing the urine sample in the cup and fastening the lid, thus beginning the assay.
- At 5 minutes of time, the results were observed. In the drug-free urine sample, a bright line was observed on the test line of all analytes for all three replicates, indicating a negative result for all analytes. In the −50% cutoff, a sample a line was observed for all analytes in all three replicates, indicating a negative result for all analytes. In the +50% cutoff samples, either no line or a very faint line appeared in each of the three replicates, indicating a positive result for all samples. In the 3× cutoff samples, no line was visible indicating a positive result.
- The invention illustratively described herein may be practiced in the absence of any element or elements, limitation or limitations that are not specifically disclosed herein. The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention that in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by various embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modifications and variations are considered to be within the scope of this invention as defined by the appended claims.
- The contents of the articles, patents, and patent applications, and all other documents and electronically available information mentioned or cited herein, are hereby incorporated by reference in their entirety to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference. Applicants reserve the right to physically incorporate into this application any and all materials and information from any such articles, patents, patent applications, or other documents.
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/091,368 US20090308185A1 (en) | 2005-10-25 | 2006-10-20 | Device for detecting analytes in fluid samples |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005101139775A CN100478671C (en) | 2005-10-25 | 2005-10-25 | Detector and method for liquid sampler |
CN200510113977.5 | 2005-10-25 | ||
US11/260496 | 2005-10-26 | ||
US11/260,496 US9011770B2 (en) | 2005-10-25 | 2005-10-26 | Device for detecting analytes in fluid samples |
PCT/GB2006/003910 WO2007049010A1 (en) | 2005-10-25 | 2006-10-20 | Device for detecting analytes in fluid samples |
US12/091,368 US20090308185A1 (en) | 2005-10-25 | 2006-10-20 | Device for detecting analytes in fluid samples |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090308185A1 true US20090308185A1 (en) | 2009-12-17 |
Family
ID=37610097
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/260,496 Active 2030-08-24 US9011770B2 (en) | 2005-10-25 | 2005-10-26 | Device for detecting analytes in fluid samples |
US12/091,368 Abandoned US20090308185A1 (en) | 2005-10-25 | 2006-10-20 | Device for detecting analytes in fluid samples |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/260,496 Active 2030-08-24 US9011770B2 (en) | 2005-10-25 | 2005-10-26 | Device for detecting analytes in fluid samples |
Country Status (10)
Country | Link |
---|---|
US (2) | US9011770B2 (en) |
EP (1) | EP1963855B1 (en) |
JP (1) | JP4889743B2 (en) |
CN (1) | CN100478671C (en) |
AU (1) | AU2006307726B2 (en) |
CA (1) | CA2624971C (en) |
DE (1) | DE212006000063U1 (en) |
IL (1) | IL191071A (en) |
NZ (1) | NZ566814A (en) |
WO (1) | WO2007049010A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130045501A1 (en) * | 2010-03-25 | 2013-02-21 | Lin Hu | Detection Device for Detecting Analytes in Liquid Specimen |
CN104655862A (en) * | 2015-01-19 | 2015-05-27 | 路建磊 | Urine collection and analysis equipment |
EP3060343A4 (en) * | 2013-10-22 | 2017-08-09 | Abon Biohparm (Hangzhou) Co., Ltd | A testing device for testing analytes in liquid samples |
USD910200S1 (en) | 2018-12-21 | 2021-02-09 | Lucira Health, Inc. | Test tube |
US11080848B2 (en) | 2017-04-06 | 2021-08-03 | Lucira Health, Inc. | Image-based disease diagnostics using a mobile device |
US11125661B2 (en) | 2016-03-14 | 2021-09-21 | Lucira Health. Inc. | Devices and methods for biological assay sample preparation and delivery |
US11123736B2 (en) | 2016-03-14 | 2021-09-21 | Lucira Health, Inc. | Systems and methods for performing biological assays |
US11291995B2 (en) | 2016-03-14 | 2022-04-05 | Lucira Health, Inc. | Selectively vented biological assay devices and associated methods |
US20220113224A1 (en) * | 2020-10-12 | 2022-04-14 | Xiyuan Sun | Analytical system comprising sample management module and method thereof |
USD953561S1 (en) | 2020-05-05 | 2022-05-31 | Lucira Health, Inc. | Diagnostic device with LED display |
USD962470S1 (en) | 2020-06-03 | 2022-08-30 | Lucira Health, Inc. | Assay device with LCD display |
US11465142B2 (en) | 2017-09-14 | 2022-10-11 | Lucira Health, Inc. | Multiplexed biological assay device with electronic readout |
US11584957B2 (en) | 2014-04-24 | 2023-02-21 | Lucira Health, Inc. | Colorimetric detection of nucleic acid amplification |
WO2023038967A1 (en) * | 2021-09-08 | 2023-03-16 | President And Fellows Of Harvard College | Systems and methods for controlling fluid flow between multiple chambers of a testing device |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7560272B2 (en) | 2003-01-04 | 2009-07-14 | Inverness Medical Switzerland Gmbh | Specimen collection and assay container |
US7727206B2 (en) * | 2005-12-27 | 2010-06-01 | Gorres Geoffrey H | Device for monitoring a patient for a urinary tract infection |
US7871568B2 (en) * | 2006-01-23 | 2011-01-18 | Quidel Corporation | Rapid test apparatus |
US7794656B2 (en) * | 2006-01-23 | 2010-09-14 | Quidel Corporation | Device for handling and analysis of a biological sample |
US20090269247A1 (en) * | 2008-04-29 | 2009-10-29 | Robert Lee Grenz | Fluid collection device with expresser plug holder |
US8511149B2 (en) | 2008-07-07 | 2013-08-20 | Hangzhou D2 Technology Co., Ltd | Detection device for fluid sample |
CN102012421B (en) * | 2009-09-07 | 2014-04-09 | 艾博生物医药(杭州)有限公司 | Detection device for analyzing analyte in liquid sample |
CN101943696B (en) * | 2009-07-09 | 2014-05-07 | 艾博生物医药(杭州)有限公司 | Detection device for analyzing analyte in liquid sample |
CN102072950B (en) * | 2009-11-23 | 2013-12-25 | 艾博生物医药(杭州)有限公司 | Device for detecting analyzed substance in sample |
CN102087295B (en) | 2011-01-24 | 2013-04-03 | 杭州安旭科技有限公司 | Rapid detecting device |
US9352312B2 (en) | 2011-09-23 | 2016-05-31 | Alere Switzerland Gmbh | System and apparatus for reactions |
JP5467140B2 (en) * | 2011-11-10 | 2014-04-09 | エイペックス バイオテクノロジー コーポレイション | Biochemical assay device |
CN102768206A (en) * | 2012-07-03 | 2012-11-07 | 万华普曼生物工程有限公司 | Body fluid detection device |
US9272277B2 (en) * | 2013-02-15 | 2016-03-01 | Honeywell International Inc. | Capillary groove for isobaric waste entry |
EP2991766B1 (en) * | 2013-04-30 | 2018-01-17 | Microtri Limited | Bodily fluid specimen collection and assay device |
WO2015070712A1 (en) * | 2013-11-14 | 2015-05-21 | Abon Biopharm (Hangzhou) Co., Ltd. | A device and method for using the device |
CN104697816A (en) * | 2013-12-05 | 2015-06-10 | 艾博生物医药(杭州)有限公司 | Device and method |
EP3077788A4 (en) * | 2013-12-05 | 2017-05-10 | Abon Biohparm (Hangzhou) Co., Ltd | Device and method |
WO2015138343A1 (en) | 2014-03-10 | 2015-09-17 | Click Diagnostics, Inc. | Cartridge-based thermocycler |
MX2016011866A (en) | 2014-04-25 | 2017-05-10 | Siemens Healthcare Diagnostics Inc | High throughput fabrication of soft machines. |
CN104007237B (en) * | 2014-05-30 | 2016-01-20 | 广州万孚生物技术股份有限公司 | The liquid detection cup of tool control device and liquid detecting method |
US9987633B2 (en) * | 2014-06-09 | 2018-06-05 | 3M Innovative Properties Company | Assay devices and method of detecting a target analyte |
CN114958990A (en) | 2014-12-31 | 2022-08-30 | 维斯比医学公司 | Method for detecting target nucleic acid using molecular diagnostic test device |
CN108700564B (en) * | 2015-11-09 | 2021-09-24 | 诺凡麦制药有限公司 | Body fluid collection and diagnostic device |
WO2017185067A1 (en) | 2016-04-22 | 2017-10-26 | Click Diagnostics, Inc. | Printed circuit board heater for an amplification module |
WO2017197040A1 (en) | 2016-05-11 | 2017-11-16 | Click Diagnostics, Inc. | Devices and methods for nucleic acid extraction |
CN105891494B (en) * | 2016-06-14 | 2017-09-26 | 焦作百奥泰科生物科技有限公司 | A kind of fluorescence immune chromatography test paper for detecting citrinin |
USD800331S1 (en) | 2016-06-29 | 2017-10-17 | Click Diagnostics, Inc. | Molecular diagnostic device |
MX2018015889A (en) | 2016-06-29 | 2019-05-27 | Click Diagnostics Inc | Devices and methods for the detection of molecules using a flow cell. |
USD800913S1 (en) | 2016-06-30 | 2017-10-24 | Click Diagnostics, Inc. | Detection window for molecular diagnostic device |
USD800914S1 (en) | 2016-06-30 | 2017-10-24 | Click Diagnostics, Inc. | Status indicator for molecular diagnostic device |
CN106442013A (en) * | 2016-12-01 | 2017-02-22 | 安徽贝驰生物科技有限公司 | Vacuum self-suction type liquid detection device |
CN106771163B (en) * | 2016-12-14 | 2018-12-21 | 上海默礼生物医药科技有限公司 | A kind of liquid detecting box and its detection method with control device |
CN111655866A (en) | 2017-11-09 | 2020-09-11 | 维斯比医学公司 | Portable molecular diagnostic device and method for detecting target virus |
CN209656722U (en) * | 2018-02-13 | 2019-11-19 | 杭州博拓生物科技股份有限公司 | A kind of device for collecting liquid sample |
CN208860630U (en) * | 2018-05-03 | 2019-05-14 | 浙江东方基因生物制品股份有限公司 | A kind of fluid specimen collection device |
CN110068695B (en) * | 2019-04-19 | 2024-02-06 | 成都恩普生医疗科技有限公司 | Handheld portable automatic urine analysis instrument device |
CN110101416A (en) * | 2019-05-23 | 2019-08-09 | 广州云雾雾化应用技术研究院(普通合伙) | Detector |
US11752299B2 (en) * | 2019-12-15 | 2023-09-12 | Advocath LLC | Self-intermittent urinary catheter extension with infection detection, a catheter assembly having an extension with infection detection and a catheter assembly having infection detection |
US11752298B2 (en) * | 2019-12-15 | 2023-09-12 | Advocath LLC | Self-intermittent urinary catheter extension with infection detection, a catheter assembly having an extension with infection detection and a catheter assembly having infection detection |
AU2020202121A1 (en) * | 2020-03-02 | 2021-09-16 | Zhejiang Orient Gene Biotech Co., LTD | Detection device |
US11376588B2 (en) | 2020-06-10 | 2022-07-05 | Checkable Medical Incorporated | In vitro diagnostic device |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4976923A (en) * | 1989-05-12 | 1990-12-11 | Rhode Island Hospital | Sample container |
US5429804A (en) * | 1994-07-15 | 1995-07-04 | Sayles; Philip W. | One-step testing device |
US6150178A (en) * | 1999-03-24 | 2000-11-21 | Avitar, Inc. | Diagnostic testing device |
US6464939B1 (en) * | 2000-07-06 | 2002-10-15 | Varian, Inc. | Saliva testing and confirmation device |
US20030064526A1 (en) * | 2001-09-28 | 2003-04-03 | Orasure Technologies, Inc. | Sample collector and test device |
US6726879B2 (en) * | 2001-05-21 | 2004-04-27 | Ameditech, Inc. | Dual chambered fluid specimen testing device and method |
US20050119589A1 (en) * | 2003-11-14 | 2005-06-02 | Tung Hsiaoho E. | Rapid sample collection and analysis device and methods of use |
US20060029517A1 (en) * | 2004-08-03 | 2006-02-09 | Hartselle R L | Specimen collection, storage, transportation and assaying device |
US7114403B2 (en) * | 2003-05-30 | 2006-10-03 | Oakville Hong Kong Co., Ltd | Fluid collection and application device and methods of use of same |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4409989A (en) | 1981-09-14 | 1983-10-18 | Daniel Larribas | Urine specimen cup |
US6645758B1 (en) * | 1989-02-03 | 2003-11-11 | Johnson & Johnson Clinical Diagnostics, Inc. | Containment cuvette for PCR and method of use |
US5238652A (en) | 1990-06-20 | 1993-08-24 | Drug Screening Systems, Inc. | Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques |
US5464775A (en) | 1991-09-16 | 1995-11-07 | Chimera Research And Chemical, Inc. | Method of detecting adulterant in urine |
JPH06347385A (en) * | 1991-11-22 | 1994-12-22 | La Mina Ltd | Living-organism-fluid testing device |
JP3357196B2 (en) * | 1994-09-13 | 2002-12-16 | 積水化学工業株式会社 | Fecal occult blood determination device |
JP3010699U (en) | 1994-10-29 | 1995-05-02 | 株式会社ニッポンジーン | Chromatographic inspection device capable of direct urine collection |
CA2167362A1 (en) * | 1995-02-10 | 1996-08-11 | Alexei Dmitri Klimov | Apparatus and method for conducting a binding assay on an absorbent carrier material |
US5874216A (en) | 1996-02-23 | 1999-02-23 | Ensys Environmental Products, Inc. | Indirect label assay device for detecting small molecules and method of use thereof |
US6372515B1 (en) | 1996-03-11 | 2002-04-16 | American Bio Medica Corporation | Device for the testing of fluid samples and process for making the device |
US6406922B2 (en) | 1996-03-11 | 2002-06-18 | American Bio Medica Corp. | Device for the testing of body fluid samples |
US6514461B1 (en) * | 1997-02-14 | 2003-02-04 | Escreen, Inc. | System for automatically testing a fluid specimen |
US6342183B1 (en) * | 1997-02-14 | 2002-01-29 | Escreen | System for collecting and locally analyzing a fluid specimen |
WO1998038917A1 (en) * | 1997-03-05 | 1998-09-11 | Point Of Care Technologies, Inc. | Fluid specimen collecting and testing apparatus |
US5942442A (en) | 1997-04-02 | 1999-08-24 | The Perkin-Elmer Corporation | Detection of low level analytes in samples using agglutination reaction capillary slide test and apparatus therefor |
HUP0102458A2 (en) | 1997-11-05 | 2001-11-28 | American Bio Medica Corporation | Device for the testing of fluid samples and process for making the device |
US5968746A (en) | 1997-11-26 | 1999-10-19 | Schneider; David R. | Method and apparatus for preserving human saliva for testing |
USD423110S (en) | 1998-04-28 | 2000-04-18 | American BioMedica Corp. | Drug test card for drugs of abuse |
US6379620B1 (en) | 1998-11-16 | 2002-04-30 | Barry M. Tydings | Assaying device and method for in field urinalysis |
JP4026166B2 (en) * | 1998-12-21 | 2007-12-26 | 株式会社アステックコーポレーション | Urinalysis reagent cell and urinalysis container |
EP1145005A3 (en) | 1999-04-08 | 2001-12-05 | Chimera Research and Chemical, Inc. | Method for detection of analytes in urine using lateral flow hybrid device |
US6528323B1 (en) | 1999-06-14 | 2003-03-04 | Praxsys Biosystems, Inc. | Bidirectional lateral flow test strip and method |
US6514769B2 (en) | 1999-07-29 | 2003-02-04 | Jin Po Lee | Multiple analyte assay device with sample integrity monitoring system |
JP2001116739A (en) * | 1999-08-06 | 2001-04-27 | Sekisui Chem Co Ltd | Instrument for inspection |
USD430303S (en) | 1999-11-01 | 2000-08-29 | American Biomedica Corporation | Drug test card for drugs of abuse |
EP1230545B1 (en) | 1999-11-12 | 2006-01-11 | Tuan Pham | Diagnostic testing kit for collection and testing of fluid samples with user configurable test strips and timer |
US6383736B1 (en) | 2000-02-29 | 2002-05-07 | Ted Titmas | Personal drug use indicator |
US7244392B1 (en) | 2000-05-22 | 2007-07-17 | Inverness Medical Switzerland Gmbh | Slide-in cassette for a cup for testing of drugs of abuse |
US6374684B1 (en) * | 2000-08-25 | 2002-04-23 | Cepheid | Fluid control and processing system |
US6663831B2 (en) | 2001-04-04 | 2003-12-16 | Forefront Diagnostics, Inc. | “One-device” system for testing constituents in fluids |
US20030007892A1 (en) | 2001-07-09 | 2003-01-09 | Smith Jack V. | UA cup |
US7300633B2 (en) * | 2001-07-25 | 2007-11-27 | Oakville Hong Kong Company Limited | Specimen collection container |
KR100417858B1 (en) * | 2001-07-27 | 2004-02-05 | 주식회사 하이닉스반도체 | Low power type rambus dram |
US7384598B2 (en) * | 2001-12-21 | 2008-06-10 | Kimberly-Clark Worldwide, Inc. | Diagnostic device |
US20040182795A1 (en) * | 2003-03-21 | 2004-09-23 | Randel Dorian | Apparatus and method for concentration of plasma from whole blood |
US7482116B2 (en) * | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
US7560272B2 (en) | 2003-01-04 | 2009-07-14 | Inverness Medical Switzerland Gmbh | Specimen collection and assay container |
US20040133128A1 (en) | 2003-01-04 | 2004-07-08 | Zhumin Guan | Assay device with attachable seal for use with specimen collection and assay containers |
US20040184965A1 (en) | 2003-03-18 | 2004-09-23 | Smith Jack V. | Testing cup |
CN1823273B (en) | 2003-07-11 | 2012-05-30 | 因韦尔尼斯医药瑞士股份有限公司 | Compact analyte testing cassette with true positive and negative analyte controls |
US20050009203A1 (en) | 2003-07-11 | 2005-01-13 | Wong Johnson N.S. | Multi-drug testing device and method |
US7517495B2 (en) * | 2003-08-25 | 2009-04-14 | Inverness Medical Switzerland Gmbh | Biological specimen collection and analysis system |
US20050053519A1 (en) | 2003-09-10 | 2005-03-10 | Smith Jack V. | Delta cup |
JP4745245B2 (en) | 2003-11-14 | 2011-08-10 | アレル・スウイツツアーランド・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Sample collection cup with integrated operable sample analysis system |
AU2004291922B2 (en) | 2003-11-14 | 2009-11-19 | Abbott Rapid Diagnostics International Unlimited Company | Sample collection cup with integrated sample analysis system |
US8511149B2 (en) * | 2008-07-07 | 2013-08-20 | Hangzhou D2 Technology Co., Ltd | Detection device for fluid sample |
-
2005
- 2005-10-25 CN CNB2005101139775A patent/CN100478671C/en active Active
- 2005-10-26 US US11/260,496 patent/US9011770B2/en active Active
-
2006
- 2006-10-20 CA CA2624971A patent/CA2624971C/en active Active
- 2006-10-20 DE DE212006000063U patent/DE212006000063U1/en not_active Expired - Lifetime
- 2006-10-20 WO PCT/GB2006/003910 patent/WO2007049010A1/en active Application Filing
- 2006-10-20 NZ NZ566814A patent/NZ566814A/en unknown
- 2006-10-20 EP EP06794848.9A patent/EP1963855B1/en active Active
- 2006-10-20 JP JP2008537177A patent/JP4889743B2/en not_active Expired - Fee Related
- 2006-10-20 US US12/091,368 patent/US20090308185A1/en not_active Abandoned
- 2006-10-20 AU AU2006307726A patent/AU2006307726B2/en active Active
-
2008
- 2008-04-27 IL IL191071A patent/IL191071A/en active IP Right Grant
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4976923A (en) * | 1989-05-12 | 1990-12-11 | Rhode Island Hospital | Sample container |
US5429804A (en) * | 1994-07-15 | 1995-07-04 | Sayles; Philip W. | One-step testing device |
US6150178A (en) * | 1999-03-24 | 2000-11-21 | Avitar, Inc. | Diagnostic testing device |
US6464939B1 (en) * | 2000-07-06 | 2002-10-15 | Varian, Inc. | Saliva testing and confirmation device |
US6726879B2 (en) * | 2001-05-21 | 2004-04-27 | Ameditech, Inc. | Dual chambered fluid specimen testing device and method |
US20030064526A1 (en) * | 2001-09-28 | 2003-04-03 | Orasure Technologies, Inc. | Sample collector and test device |
US7114403B2 (en) * | 2003-05-30 | 2006-10-03 | Oakville Hong Kong Co., Ltd | Fluid collection and application device and methods of use of same |
US20050119589A1 (en) * | 2003-11-14 | 2005-06-02 | Tung Hsiaoho E. | Rapid sample collection and analysis device and methods of use |
US20050202568A1 (en) * | 2003-11-14 | 2005-09-15 | Tung Hsiaoho E. | Fluid sample analysis device with sealable sample storage reservoir |
US20090117665A1 (en) * | 2003-11-14 | 2009-05-07 | Inverness Medical Switzerland Gmbh | Rapid sample collection and analysis device and methods of use |
US20060029517A1 (en) * | 2004-08-03 | 2006-02-09 | Hartselle R L | Specimen collection, storage, transportation and assaying device |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130045501A1 (en) * | 2010-03-25 | 2013-02-21 | Lin Hu | Detection Device for Detecting Analytes in Liquid Specimen |
US10073088B2 (en) * | 2010-03-25 | 2018-09-11 | ABON Biopharm (Hangzhou) Co., Ltd | Detection device for detecting analytes in liquid specimen |
US11131662B2 (en) | 2010-03-25 | 2021-09-28 | Abon Biopharm (Hangzhou) Co., Ltd. | Detection device for detecting analytes in liquid specimen |
EP3060343A4 (en) * | 2013-10-22 | 2017-08-09 | Abon Biohparm (Hangzhou) Co., Ltd | A testing device for testing analytes in liquid samples |
US10495635B2 (en) | 2013-10-22 | 2019-12-03 | Abon Biopharm (Hangzhou) Co., Ltd. | Testing device for testing analytes in liquid samples |
US11584957B2 (en) | 2014-04-24 | 2023-02-21 | Lucira Health, Inc. | Colorimetric detection of nucleic acid amplification |
CN104655862A (en) * | 2015-01-19 | 2015-05-27 | 路建磊 | Urine collection and analysis equipment |
US11123736B2 (en) | 2016-03-14 | 2021-09-21 | Lucira Health, Inc. | Systems and methods for performing biological assays |
US11125661B2 (en) | 2016-03-14 | 2021-09-21 | Lucira Health. Inc. | Devices and methods for biological assay sample preparation and delivery |
US11291995B2 (en) | 2016-03-14 | 2022-04-05 | Lucira Health, Inc. | Selectively vented biological assay devices and associated methods |
US11080848B2 (en) | 2017-04-06 | 2021-08-03 | Lucira Health, Inc. | Image-based disease diagnostics using a mobile device |
US11954851B2 (en) | 2017-04-06 | 2024-04-09 | Pfizer Inc. | Image-based disease diagnostics using a mobile device |
US11465142B2 (en) | 2017-09-14 | 2022-10-11 | Lucira Health, Inc. | Multiplexed biological assay device with electronic readout |
USD910200S1 (en) | 2018-12-21 | 2021-02-09 | Lucira Health, Inc. | Test tube |
USD953561S1 (en) | 2020-05-05 | 2022-05-31 | Lucira Health, Inc. | Diagnostic device with LED display |
USD962470S1 (en) | 2020-06-03 | 2022-08-30 | Lucira Health, Inc. | Assay device with LCD display |
US20220113224A1 (en) * | 2020-10-12 | 2022-04-14 | Xiyuan Sun | Analytical system comprising sample management module and method thereof |
US11933700B2 (en) * | 2020-10-12 | 2024-03-19 | Xiyuan Sun | Analytical system comprising sample management module and method thereof |
WO2023038967A1 (en) * | 2021-09-08 | 2023-03-16 | President And Fellows Of Harvard College | Systems and methods for controlling fluid flow between multiple chambers of a testing device |
Also Published As
Publication number | Publication date |
---|---|
CN100478671C (en) | 2009-04-15 |
CA2624971C (en) | 2016-09-13 |
JP2009513967A (en) | 2009-04-02 |
CN1834622A (en) | 2006-09-20 |
AU2006307726B2 (en) | 2012-04-19 |
CA2624971A1 (en) | 2007-05-03 |
WO2007049010A1 (en) | 2007-05-03 |
US9011770B2 (en) | 2015-04-21 |
NZ566814A (en) | 2011-06-30 |
AU2006307726A1 (en) | 2007-05-03 |
US20070092402A1 (en) | 2007-04-26 |
IL191071A (en) | 2013-04-30 |
EP1963855B1 (en) | 2018-04-25 |
JP4889743B2 (en) | 2012-03-07 |
DE212006000063U1 (en) | 2008-07-03 |
IL191071A0 (en) | 2008-12-29 |
EP1963855A1 (en) | 2008-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9011770B2 (en) | Device for detecting analytes in fluid samples | |
US11131662B2 (en) | Detection device for detecting analytes in liquid specimen | |
US7837939B2 (en) | Rapid sample collection and analysis device and methods of use | |
US8206661B2 (en) | Assay device and process for the testing of fluid samples | |
EP1687620B1 (en) | Sample collection cup with integrated sample analysis system | |
CN110161266B (en) | Method for collecting liquid sample | |
EP4012408B1 (en) | Sample collection and detection device and method | |
EP4092412A1 (en) | Blood collection structure, and whole blood and fingerstick blood detection device and method | |
EP2464965B1 (en) | Detection device and method of using the same | |
WO2017084540A1 (en) | Collection and detection device for fluid samples | |
CN212514605U (en) | Detection device | |
WO2022213407A1 (en) | Blood collection structure, and whole blood and fingerstick blood detection device and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INVERNESS MEDICAL SWITZERLAND GMBH, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:OAKVILLE HONG KONG CO., LTD.;REEL/FRAME:024959/0430 Effective date: 20100601 Owner name: ALERE SWITZERLAND GMBH, SWITZERLAND Free format text: CHANGE OF NAME;ASSIGNOR:INVERNESS MEDICAL SWITZERLAND GMBH;REEL/FRAME:024959/0532 Effective date: 20100308 Owner name: ACON BIOTECH (HANGZHOU) CO., LTD., CHINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WU, YUZHANG;HU, HAIPENG;DAI, JIELIN;AND OTHERS;SIGNING DATES FROM 20091228 TO 20100113;REEL/FRAME:024959/0317 Owner name: OAKVILLE HONG KONG CO., LTD., HONG KONG Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACON BIOTECH (HANGZHOU) CO., LTD.;REEL/FRAME:024959/0407 Effective date: 20100601 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |